William Mack & Associates
THC icon

William Mack & Associates’s Tenet Healthcare THC Stock Holding History

William Mack & Associates’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$767 Buy
+3
New +$738 ﹤0.01% 779

Other funds holding THC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

William Mack & Associates's THC Position: Q3 2026 in Review

William Mack & Associates opened a new position in Tenet Healthcare (THC) in Q3 2026: 3 shares worth $767. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings.

635 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • William Mack & Associates held 3 shares of Tenet Healthcare worth $767 as of Q3 2026.
  • Tenet Healthcare was a new William Mack & Associates position in Q3 2026.
  • Tenet Healthcare made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #779 holding.
  • 635 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.